Compare INBK & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBK | TKNO |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | United States |
| Employees | N/A | 158 |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.0M | 482.7M |
| IPO Year | 2013 | 2021 |
| Metric | INBK | TKNO |
|---|---|---|
| Price | $27.11 | $8.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $30.90 | $9.00 |
| AVG Volume (30 Days) | 37.0K | ★ 220.7K |
| Earning Date | 10-21-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 0.55 | N/A |
| Revenue | $11,541,000.00 | ★ $40,520,000.00 |
| Revenue This Year | $18.94 | $13.53 |
| Revenue Next Year | $14.34 | $14.01 |
| P/E Ratio | $47.40 | ★ N/A |
| Revenue Growth | ★ 101.84 | 7.35 |
| 52 Week Low | $17.05 | $1.91 |
| 52 Week High | $31.09 | $9.48 |
| Indicator | INBK | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 70.25 |
| Support Level | $25.04 | $4.87 |
| Resistance Level | $30.04 | N/A |
| Average True Range (ATR) | 0.89 | 0.51 |
| MACD | -0.16 | 0.09 |
| Stochastic Oscillator | 40.87 | 84.29 |
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.